FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, which have the activity of inhibiting apical sodium-dependent bile acid transporter (ASBT) and/or hepatic bile acid transporter (LBAT). In formula (I) M is selected from -CH2- and -NR7-; R1 is C1-4alkyl; R2 is independently selected from the group consisting of hydrogen and halogen; n is equal to integer 1, 2 or 3; R3 is selected from the group consisting of C1-4alkoxy, C3-6cycloalkyloxy, C1-4alkylthio and C3-6cycloalkylthio; one of R4 and R5 is carboxyl, and the other of R4 and R5 is selected from the group consisting of hydrogen and fluorine; R6 is hydrogen and R7 is selected from the group consisting of hydrogen and C1-4alkyl. Invention also relates to a pharmaceutical composition containing said compound and use thereof as a drug possessing the activity of inhibiting apical sodium-dependent bile acid transporter (ASBT) and/or hepatic bile acid transporter (LBAT).
EFFECT: disclosed are benzothia(di)azepine compounds and use thereof as bile acid modulators.
14 cl, 4 dwg, 8 tbl, 62 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOTHIA (DI) AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838220C1 |
BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS | 2019 |
|
RU2785867C2 |
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2021 |
|
RU2841263C1 |
BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACIDS MODULATORS | 2020 |
|
RU2814570C2 |
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838460C1 |
BENZOTHIADIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838136C1 |
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2817535C2 |
N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
FGF21 DERIVATIVES AND USE THEREOF | 2015 |
|
RU2729011C2 |
TARTRATE 3-((1R,3R)-1-(2,6-DIFLUORINE-4-((1-(3- FLUOROPROPYL)AZETIDINE-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-b]INDOLE-2-YL)-2,2-DIFLUOROPROPANE-1-OL, ITS SOLID FORMS, METHOD OF ITS PREPARATION AND THEIR APPLICATION | 2019 |
|
RU2809220C2 |
Authors
Dates
2024-10-01—Published
2020-12-04—Filed